Fusion Antibodies PLC (“Fusion Antibodies”, “we”, “our”, “us”) is committed to acting ethically and with integrity in all our business activities and relationships. We oppose modern slavery and human trafficking in all its forms and take steps to ensure that it does not take place in our organisation or in our supply chains.
1. Our Business
Fusion Antibodies is a contract research organisation providing a range of antibody discovery, engineering and supply services to the life sciences sector. We are headquartered in Northern Ireland, with clients worldwide.
2. Our Commitment
-
We will not knowingly work with any organisation that supports or is involved in slavery, servitude, forced labour or human trafficking.
-
We operate policies and processes designed to identify and mitigate the risk of modern slavery in our business and supply chains.
-
We expect our suppliers and partners to uphold the same high standards.
3. Supply Chains
Our supply chains include laboratory consumables, IT equipment, professional services, and facilities management. While the risk of modern slavery in these areas is considered low, we continue to apply due diligence and maintain awareness of higher-risk categories.
4. Policies and Procedures
-
Code of Conduct sets standards for ethical business behaviour.
-
Supplier Standards require compliance with laws and human rights principles.
-
Whistleblowing Policy encourages employees and contractors to raise concerns about unethical behaviour or practices without fear of retaliation.
5. Training and Awareness
We provide training and resources to relevant staff to raise awareness of the risks of modern slavery and human trafficking, and to ensure they understand how to identify and report concerns.
6. Monitoring and Due Diligence
-
We review key suppliers periodically to assess compliance with our standards.
-
We seek contractual commitments from suppliers where appropriate.
-
We will take steps to end relationships with any supplier that does not align with our values.
7. Future Actions
We are committed to continuous improvement. In the coming year we intend to:
-
Enhance our supplier vetting process with a specific focus on labour practices.
-
Strengthen monitoring procedures across our supply chains.
-
Publish updates on progress in subsequent statements.
8. Approval
This statement is made under section 54(1) of the Modern Slavery Act 2015 and constitutes our slavery and human trafficking statement for the financial year ending [insert year].
Signed,
[Director’s Name]
Director
Fusion Antibodies PLC
Date: [insert date]